RPAM
FPRX

Rhenman & Partners Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Rhenman & Partners Asset Management’s Portfolio FPRX Stock Details FPRX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-250,000
Closed -$4.25M – 95
2020
Q4 		$4.25M Buy
+250,000
New +$4.25M 0.35% 69